Varda Space Industries Raises $187 Million to Transform Space-Based Drug Production
In a daring step towards restructuring the pharmaceutical sector, Varda Space Industries has raised $187 million in Series C funding, increasing its capital to $329 million. Natural Capital and Shrug Capital led the round, with prominent participation from players such as Peter Thiel, Lux Capital, Khosla Ventures, and Caffeinated Capital.